Myocardial viability assessment in patients with highly impaired left ventricular function: comparison of delayed enhancement, dobutamine stress MRI, end-diastolic wall thickness, and TI201-SPECT with functional recovery after revascularization
暂无分享,去创建一个
R. Felix | R. Hetzer | H. Amthauer | B. Schnackenburg | R. Hetzer | M. Gutberlet | H. Hausmann | R. Felix | M. Plotkin | J. Ruf | T. Denecke | H. Amthauer | T. Denecke | J. Ruf | M. Gutberlet | M. Fröhlich | S. Mehl | H. Hausmann | R. Meyer | H. Siniawski | M. Plotkin | B. Schnackenburg | H. Siniawski | R. Meyer | S. Mehl | T. Denecke | H. Amthauer | M. Gutberlet | M. Fröhlich | R. Hetzer
[1] M. Verani,et al. Dobutamine echocardiography and quantitative rest-redistribution 201Tl tomography in myocardial hibernation. Relation of contractile reserve to 201Tl uptake and comparative prediction of recovery of function. , 1997, Circulation.
[2] R. Kim,et al. Contrast-enhanced MRI and routine single photon emission computed tomography (SPECT) perfusion imaging for detection of subendocardial myocardial infarcts: an imaging study , 2003, The Lancet.
[3] J Knuuti,et al. Multimodality MR imaging assessment of myocardial viability: combination of first-pass and late contrast enhancement to wall motion dynamics and comparison with FDG PET-initial experience. , 2000, Radiology.
[4] O. Simonetti,et al. Relationship of MRI delayed contrast enhancement to irreversible injury, infarct age, and contractile function. , 1999, Circulation.
[5] J. Sandstede. Assessment of myocardial viability by MR imaging , 2002, European Radiology.
[6] U. Sechtem,et al. Comparison of low-dose dobutamine-gradient-echo magnetic resonance imaging and positron emission tomography with [18F]fluorodeoxyglucose in patients with chronic coronary artery disease. A functional and morphological approach to the detection of residual myocardial viability. , 1995, Circulation.
[7] E. Erdmann,et al. Dobutamine magnetic resonance imaging predicts contractile recovery of chronically dysfunctional myocardium after successful revascularization. , 1998, Journal of the American College of Cardiology.
[8] T. Kaul,et al. Coronary artery bypass grafting in patients with an ejection fraction of twenty percent or less. , 1996, The Journal of thoracic and cardiovascular surgery.
[9] H. Oswald,et al. Noninvasive detection of myocardial ischemia from perfusion reserve based on cardiovascular magnetic resonance. , 2000, Circulation.
[10] J. Sýkora,et al. Attenuation correction improves the detection of viable myocardium by thallium-201 cardiac tomography in patients with previous myocardial infarction and left ventricular dysfunction , 1999, European Journal of Nuclear Medicine.
[11] B. Schnackenburg,et al. Assessment of Myocardial Viability With Contrast-Enhanced Magnetic Resonance Imaging: Comparison With Positron Emission Tomography , 2002, Circulation.
[12] E. Fleck,et al. Noninvasive diagnosis of ischemia-induced wall motion abnormalities with the use of high-dose dobutamine stress MRI: comparison with dobutamine stress echocardiography. , 1999, Circulation.
[13] M. Oudkerk,et al. Dobutamine stress MRI. Part I. Safety and feasibility of dobutamine cardiovascular magnetic resonance in patients suspected of myocardial ischemia , 2004, European Radiology.
[14] D Hahn,et al. Analysis of first-pass and delayed contrast-enhancement patterns of dysfunctional myocardium on MR imaging: use in the prediction of myocardial viability. , 2000, AJR. American journal of roentgenology.
[15] O. Simonetti,et al. The use of contrast-enhanced magnetic resonance imaging to identify reversible myocardial dysfunction. , 2000, The New England journal of medicine.
[16] R. Ehman,et al. Effect of gadolinium-DTPA on the magnetic relaxation times of normal and infarcted myocardium. , 1984, Radiology.
[17] D. Berman,et al. Automatic quantification of ejection fraction from gated myocardial perfusion SPECT. , 1995, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[18] I G Zubal,et al. Extracardiac activity complicates quantitative cardiac SPECT imaging using a simultaneous transmission-emission approach. , 1997, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[19] R O Bonow,et al. Contrast magnetic resonance imaging in the assessment of myocardial viability in patients with stable coronary artery disease and left ventricular dysfunction. , 1998, Circulation.
[20] R Härkönen,et al. Myocardial viability: fluorine-18-deoxyglucose positron emission tomography in prediction of wall motion recovery after revascularization. , 1994, American heart journal.
[21] A de Roos,et al. MR imaging of acute myocardial infarction: value of Gd-DTPA. , 1988, AJR. American journal of roentgenology.
[22] M. Oudkerk,et al. Dobutamine stress MRI. Part II. Risk stratification with dobutamine cardiovascular magnetic resonance in patients suspected of myocardial ischemia , 2004, European Radiology.
[23] F J Ten Cate,et al. Prediction of improvement of regional left ventricular function after surgical revascularization. A comparison of low-dose dobutamine echocardiography with 201Tl single-photon emission computed tomography. , 1995, Circulation.
[24] E. Erdmann,et al. Comparison of dobutamine transesophageal echocardiography and dobutamine magnetic resonance imaging for detection of residual myocardial viability. , 1996, The American journal of cardiology.
[25] J. Dahl,et al. Diagnostik der Myokardvitalität bei chronischer Myokardischämie mit nuklearmedizinischen Verfahren , 1998, Zeitschrift für Kardiologie.
[26] M. Reiser,et al. Assessment of myocardial perfusion using multisection first-pass MRI and color-coded parameter maps: a comparison to 99mTc Sesta MIBI SPECT and systolic myocardial wall thickening analysis. , 1999, Magnetic resonance imaging.
[27] H. Amthauer,et al. Factors excercising an influence on recovery of hibernating myocardium after coronary artery bypass grafting. , 2004, European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery.
[28] S. Maderwald,et al. Steady-state free precession sequences in myocardial first-pass perfusion MR imaging: comparison with TurboFLASH imaging , 2004, European Radiology.
[29] A. Roos,et al. Contrast enhanced and functional magnetic resonance imaging for the detection of viable myocardium after infarction. , 1998, American heart journal.
[30] T L Faber,et al. Left ventricular function and perfusion from gated SPECT perfusion images: an integrated method. , 1999, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[31] M. Verani,et al. Relation of the contractile reserve of hibernating myocardium to myocardial structure in humans. , 1999, Circulation.
[32] Richard P. Lewis,et al. Guidelines for clinical use of cardiac radionuclide imaging. Report of the American College of Cardiology/American Heart Association Task Force on Assessment of Diagnostic and Therapeutic Cardiovascular Procedures (Committee on Radionuclide Imaging), developed in collaboration with the American Soci , 1995, Journal of the American College of Cardiology.
[33] R. Hetzer,et al. Decision-making in end-stage coronary artery disease: revascularization or heart transplantation? , 1997, The Annals of thoracic surgery.
[34] O. Simonetti,et al. An improved MR imaging technique for the visualization of myocardial infarction. , 2001, Radiology.
[35] U Sechtem,et al. Gradient-echo magnetic resonance imaging during incremental dobutamine infusion for the localization of coronary artery stenoses. , 1994, European heart journal.
[36] Th J A Kuijpers. Dobutamine stress MRI , 2005 .
[37] Richard P. Lewis,et al. Guidelines for clinical use of cardiac radionuclide imaging: A report of the American College of Cardiology/American Heart Association Task Force on assessment of diagnostic and therapeutic cardiovascular procedures (committee on radionuclide imaging) — Developed in collaboration with the American S , 1995, Journal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology.
[38] F. C. Dougherty,et al. Magnetic resonance imaging (MRI) in different stages of myocardial infarction using the contrast agent gadolinium‐DTPA , 1986, Clinical cardiology.